MUC5AC and pachyonychia congenita: In conclusion, the data presented in this review provide insights into the utilization of mucin family members as biomarkers and therapeutic targets in PC, and indicate further potential research areas examining new functional roles, biomarker functions and therapeutic drugs against mucins in PC.